Neurol. praxi. 2010;11(5):342-346
Intravenous thrombolysis (IVT) is currently a standard effective treatment for acute-stage ischaemic stroke. Because of the limitations
of IVT which include a short therapeutic window and a relatively low efficacy (as assessed by the recanalization of the occluded artery),
new therapeutic methods are investigated. Among the most promising are combined thrombolysis, sonothrombolysis and mechanical
removal, e. g. with the Merci catheter (all of which are being experimentally used at centres in the Czech Republic); moreover, attempts
are made to prolong the time window for treatment with IVT and to more accurately diagnose using imaging methods in acute-stage
stroke (particularly MRI DWI, MRI PWI, CT angiography and perfusion CT). To further prove the true effect on the treatment of ischaemic
stroke, more studies are required; however, their design is complicated by the dominant position of intravenous thrombolysis in early
treatment of acute stroke (it needs to be applied within 4.5 hours of the onset of stroke provided there are no contraindications, except
when occlusion of MCA or BA is confirmed where intra-arterial thrombolysis with a longer therapeutic window is also an option). Furthermore,
it is necessary to demonstrate both recanalization of the occluded artery and the positive effect on the patient's consequent
clinical condition. No therapeutic procedure which would be sufficiently effective, available and safe has been found; however, given
the number of ongoing trials with promising early results, the future certainly is hopeful.
Published: December 1, 2010 Show citation